Publications
- Cytokeratin 8/18-negative somatotroph pituitary neuroendocrine tumours (PitNETs, adenomas) show variable morphological features and do not represent a clinicopathologically distinct entity2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Stem Cell Transcription Factor Sox2 Is Expressed in a Subset of Folliculo-stellate Cells of Growth Hormone-Producing Pituitary Neuroendocrine Tumours and Its Expression Shows No Association With Tumour Size or IGF1 Levels: A Clinicopathological Study of 109 Cases2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Expression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- A Synthetic Multilocus Calibrator for Analysis of Gene Expression in Pituitary Tumors Causing Acromegaly2015 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Pharmacological management of pituitary adenomas2014 | Faculty of Medicine in Hradec Králové
- Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms2023 | Faculty of Medicine in Hradec Králové
- The interference of rheumatoid factor - case report2023 | Faculty of Medicine in Hradec Králové
- Levothyroxine suppressive therapy in differentiated thyroid cancer treatment2023 | Faculty of Medicine in Hradec Králové
Loading network view...